This company has been marked as potentially delisted and may not be actively trading. TRACON Pharmaceuticals (TCON) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock TRACON Pharmaceuticals Short Interest DataTRACON Pharmaceuticals (TCON) has a short interest of 166,100 shares, representing 6.64% of the float (the number of shares available for trading by the public). This marks a 39.58% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 120,908 shares to cover all short positions.Current Short Interest166,100 sharesPrevious Short Interest119,000 sharesChange Vs. Previous Month+39.58%Dollar Volume Sold Short$209.29 thousandShort Interest Ratio0.8 Days to CoverLast Record DateJune 15, 2024Outstanding Shares3,410,000 sharesFloat Size2,500,000 sharesShort Percent of Float6.64%Today's Trading Volume23,886 sharesAverage Trading Volume120,908 sharesToday's Volume Vs. Average20% Short Selling TRACON Pharmaceuticals? Sign up to receive the latest short interest report for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTCON Short Interest Over TimeTCON Days to Cover Over TimeTCON Percentage of Float Shorted Over Time TRACON Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2024166,100 shares $209.29 thousand +39.6%6.6%0.8 $1.26 5/31/2024119,000 shares $152.32 thousand -4.1%4.8%0.5 $1.28 5/15/2024124,100 shares $201.04 thousand -18.9%5.0%0.5 $1.62 4/30/2024153,000 shares $264.69 thousand +527.1%7.3%0.6 $1.73 4/15/202424,400 shares $43.92 thousand -96.7%1.2%0.1 $1.80 3/31/2024744,900 shares $6.40 million -60.8%N/A0.2 $8.60 3/15/20241,900,000 shares $712.50 thousand +323.5%N/A0.7 $0.38 2/29/2024448,700 shares $81.21 thousand -47.6%N/A0.2 $0.18 2/15/2024856,300 shares $162.87 thousand -29.8%N/A0.5 $0.19 1/31/20241,220,000 shares $235.95 thousand +43.0%N/A0.2 $0.19 Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024853,100 shares $144.34 thousand -52.3%N/A0.2 $0.17 12/31/20231,790,000 shares $313.43 thousand +178.9%N/A0.4 $0.18 12/15/2023641,900 shares $120.04 thousand -74.2%N/A0.1 $0.19 11/30/20232,490,000 shares $509.21 thousand +23.9%N/A0.6 $0.20 11/15/20232,010,000 shares $340.09 thousand +53.4%N/A0.5 $0.17 10/31/20231,310,000 shares $227.55 thousand +265.8%N/A1.6 $0.17 10/15/2023358,100 shares $68.76 thousand +0.8%N/A0.4 $0.19 9/30/2023355,200 shares $63.23 thousand -27.5%N/A0.6 $0.18 9/15/2023489,600 shares $124.36 thousand +21.0%N/A0.9 $0.25 8/31/2023404,700 shares $106.84 thousand +70.1%N/A0.9 $0.26 8/15/2023237,900 shares $64.00 thousand -31.8%N/A0.5 $0.27 7/31/2023348,700 shares $104.92 thousand +37.9%N/A1 $0.30 7/15/2023252,800 shares $75.71 thousand +78.5%N/A0.8 $0.30 6/30/2023141,600 shares $41.21 thousand -37.2%N/A0.5 $0.29 6/15/2023225,300 shares $114.47 thousand +38.0%N/A1 $0.51 5/31/2023163,300 shares $94.22 thousand +1.4%N/A0.9 $0.58 5/15/2023161,000 shares $104.68 thousand -38.7%N/A0.9 $0.65 4/30/2023262,500 shares $207.11 thousand +100.7%N/A1.5 $0.79 4/15/2023130,800 shares $253.75 thousand +5.7%N/A0.9 $1.94 3/31/2023123,700 shares $233.79 thousand +4.1%N/A1.5 $1.89 3/15/2023118,800 shares $180.58 thousand -16.7%N/A1.4 $1.52 2/28/2023142,600 shares $219.60 thousand -11.1%N/A0.9 $1.54 2/15/2023160,400 shares $267.87 thousand -24.6%N/A1.1 $1.67 1/31/2023212,700 shares $357.34 thousand -24.6%N/A1.3 $1.68 1/15/2023282,000 shares $502.83 thousand -21.3%N/A1.8 $1.78 12/30/2022358,200 shares $533.72 thousand +48.8%N/A2.3 $1.49 12/15/2022240,800 shares $308.22 thousand +66.9%N/A1.6 $1.28 11/30/2022144,300 shares $217.17 thousand -2.8%N/A2 $1.51 11/15/2022148,500 shares $227.21 thousand -1.5%N/A2.1 $1.53 10/31/2022150,700 shares $238.11 thousand +23.6%N/A2.1 $1.58Thirty-Year “Wonder Material” Finally Ready for Factory Floors (Ad)A Nobel-recognized material once trapped in research labs is finally ready for the real world. After a 90% cost breakthrough, this wonder-material is being tested by aerospace giants, battery developers, and chip makers alike. Now, a new briefing reveals the companies best positioned to profit from its mass adoption.See the whole incredible story here >>> 10/15/2022121,900 shares $201.14 thousand -5.9%N/A1.9 $1.65 9/30/2022129,500 shares $216.27 thousand -7.2%N/A2.1 $1.67 9/15/2022139,600 shares $262.45 thousand +6.8%N/A2.2 $1.88 8/31/2022130,700 shares $258.79 thousand -0.5%N/A2 $1.98 8/15/2022131,300 shares $278.36 thousand +5.0%N/A1.9 $2.12 7/31/2022125,100 shares $221.43 thousand -9.7%N/A1.8 $1.77 7/15/2022138,600 shares $248.09 thousand -15.4%N/A1.7 $1.79 6/30/2022163,800 shares $327.60 thousand +26.7%N/A1.8 $2.00 6/15/2022129,300 shares $173.26 thousand +0.4%N/A1.4 $1.34 5/31/2022128,800 shares $221.54 thousand -6.0%N/A1.3 $1.72 5/15/2022137,000 shares $228.79 thousand -15.5%N/A1.3 $1.67 4/30/2022162,200 shares $326.02 thousand +9.5%N/A1.6 $2.01 4/15/2022148,200 shares $371.98 thousand -18.4%N/A1.4 $2.51 3/31/2022181,600 shares $477.61 thousand -35.6%N/A1.7 $2.63 3/15/2022281,800 shares $760.86 thousand -1.8%N/A1.3 $2.70 2/28/2022287,000 shares $726.11 thousand -7.0%N/A1.2 $2.53 2/15/2022308,600 shares $802.36 thousand -0.4%N/A1.2 $2.60 1/31/2022309,700 shares $802.12 thousand -3.7%N/A1.1 $2.59 1/15/2022321,500 shares $758.74 thousand +4.7%N/A1.1 $2.36 12/31/2021307,200 shares $850.94 thousand +38.0%N/A1.1 $2.77 12/15/2021222,600 shares $560.95 thousand -0.3%N/A0.9 $2.52 11/30/2021223,300 shares $580.58 thousand -9.6%N/A1.2 $2.60 11/15/2021246,900 shares $802.43 thousand -2.1%N/A1.6 $3.25 10/29/2021252,300 shares $933.51 thousand -7.2%N/A1.7 $3.70 10/15/2021271,800 shares $1.03 million -12.2%N/A1.4 $3.78 9/30/2021309,700 shares $1.20 million +2.4%N/A1.1 $3.87 9/15/2021302,500 shares $1.15 million -39.8%N/A1.1 $3.79 8/31/2021502,100 shares $1.88 million -8.0%N/A1.7 $3.74 8/13/2021545,700 shares $1.95 million -11.5%N/A1.9 $3.57 7/30/2021616,800 shares $2.31 million -11.2%N/A2.3 $3.75 7/15/2021694,400 shares $3.60 million -1.0%N/A3.1 $5.18 6/30/2021701,500 shares $4.55 million +14.1%5.2%4.8 $6.49 6/15/2021614,800 shares $3.89 million +21.3%4.6%3.8 $6.32 5/28/2021506,800 shares $3.06 million -4.5%3.8%2.9 $6.03 5/14/2021530,500 shares $3.08 million -2.6%3.6%2.2 $5.81 4/30/2021544,600 shares $4.01 million -6.2%3.7%1.8 $7.36 4/15/2021580,800 shares $4.76 million +17.1%3.9%1.5 $8.19 3/31/2021496,000 shares $3.85 million +3.0%3.4%1.1 $7.77 3/15/2021481,400 shares $4.46 million +37.4%3.3%0.8 $9.27 2/26/2021350,500 shares $3.15 million -37.5%2.4%0.6 $9.00 2/12/2021560,500 shares $6.17 million +56.7%4.3%0.9 $11.00 1/29/2021357,800 shares $3.26 million +7.5%2.8%0.4 $9.10 1/15/2021332,800 shares $3.71 million -39.3%2.6%0.4 $11.16 12/31/2020548,000 shares $5.83 million +205.6%4.2%0.7 $10.64 12/15/2020179,300 shares $1.46 million +34.0%1.4%0.2 $8.14 11/30/2020133,800 shares $1.18 million -41.3%1.0%0.1 $8.83 11/15/2020228,100 shares $1.74 million +6.1%1.8%0.2 $7.63 10/30/2020215,000 shares $1.08 million -7.5%1.7%0.1 $5.01 10/15/2020232,300 shares $1.26 million -32.4%1.9%0.1 $5.42 9/30/2020343,500 shares $1.78 million -35.4%4.3%0.2 $5.17Thirty-Year “Wonder Material” Finally Ready for Factory Floors (Ad)A Nobel-recognized material once trapped in research labs is finally ready for the real world. After a 90% cost breakthrough, this wonder-material is being tested by aerospace giants, battery developers, and chip makers alike. Now, a new briefing reveals the companies best positioned to profit from its mass adoption.See the whole incredible story here >>> 9/15/2020531,900 shares $2.41 million +115.2%6.6%0.3 $4.53 8/31/2020247,200 shares $467.21 thousand +779.7%3.1%0.2 $1.89 8/14/202028,100 shares $48.05 thousand -54.6%0.4%0 $1.71 7/31/202061,900 shares $102.14 thousand -49.1%0.8%0.1 $1.65 7/15/2020121,500 shares $230.85 thousand +66.4%2.5%0.3 $1.90 TCON Short Interest - Frequently Asked Questions What is TRACON Pharmaceuticals' current short interest? Short interest is the volume of TRACON Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 166,100 shares of TCON short. 6.64% of TRACON Pharmaceuticals' shares are currently sold short. Learn More on TRACON Pharmaceuticals' current short interest. What is a good short interest ratio for TRACON Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCON shares currently have a short interest ratio of 1.0. Learn More on TRACON Pharmaceuticals's short interest ratio. What is a good short interest percentage for TRACON Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.64% of TRACON Pharmaceuticals' floating shares are currently sold short. Is TRACON Pharmaceuticals' short interest increasing or decreasing? TRACON Pharmaceuticals saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 166,100 shares, an increase of 39.6% from the previous total of 119,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TRACON Pharmaceuticals' float size? TRACON Pharmaceuticals currently has issued a total of 3,410,000 shares. Some of TRACON Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRACON Pharmaceuticals currently has a public float of 2,500,000 shares. How does TRACON Pharmaceuticals' short interest compare to its competitors? 6.64% of TRACON Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TRACON Pharmaceuticals: Virpax Pharmaceuticals, Inc. (0.67%), Kiromic BioPharma, Inc. (0.01%), TC Biopharm (Holdings) Plc (176.43%), Vincerx Pharma, Inc. (0.05%), Bon Natural Life Limited (97.97%), Smart for Life, Inc. (0.01%), Navidea Biopharmaceuticals, Inc. (0.00%), Scopus BioPharma Inc. (0.03%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors Company ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply Company ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short TRACON Pharmaceuticals stock? Short selling TCON is an investing strategy that aims to generate trading profit from TRACON Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TRACON Pharmaceuticals? A short squeeze for TRACON Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCON, which in turn drives the price of the stock up even further. How often is TRACON Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCON, twice per month. The most recent reporting period available is June, 15 2024. More Short Interest Resources from MarketBeat Related Companies VRPX Short Interest KRBP Short Interest TCBP Short Interest VINC Short Interest BON Short Interest SMFL Short Interest NAVB Short Interest SCPS Short Interest EVLO Short Interest CMRA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCON) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
